Advance development of KeraStat Cream as a medical device
Award Notice Posted
- Solicitation number
- 75A50122C00017
- Agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Awarded
- to Keranetics Inc.
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75A50122C00017 Federal contract award
- NAICS code
- Not on record
- Place of performance
- Winston Salem, North Carolina 27101, United States
Notice details come from SAM.gov. Updated .
About this opportunity
This Award Notice from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded Keranetics, LLC a cost reimbursable contract to advance the development of KeraStat Cream as a medical device for the treatment of cutaneous radiation injury. The contract number 75A50122C00017, awarded on March 18, 2022, includes $2,848,309 for pivotal non-clinical studies, $643,964 for 510(k) regulatory submission, $582,087 for engineering scale-up options, and $395,952 for equipment installation and quality management system updates, for a total value of $4,471,066.
Notice text
Research and Development effort awarded under Broad Agency Annoouncement and cost reimbursable work to develop a proprietary cream to treat radiation injury burns.
Awarded contract 75A50122C00017 to Keranetics, LLC for 4471066.00 on 2022-03-18.
Files
| File | Type | Posted |
|---|---|---|
| Temporary I.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| To advance the development of KeraStat® Cream as a treatment of Cutaneous Radiation Injury (CRI). | Award Notice | |
| This notice | Award Notice |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity